288 related articles for article (PubMed ID: 16256093)
1. In vivo cholinesterase inhibitory specificity of organophosphorus nerve agents.
Shih TM; Kan RK; McDonough JH
Chem Biol Interact; 2005 Dec; 157-158():293-303. PubMed ID: 16256093
[TBL] [Abstract][Full Text] [Related]
2. Evaluation of nine oximes on in vivo reactivation of blood, brain, and tissue cholinesterase activity inhibited by organophosphorus nerve agents at lethal dose.
Shih TM; Skovira JW; O'Donnell JC; McDonough JH
Toxicol Mech Methods; 2009 Sep; 19(6-7):386-400. PubMed ID: 19778239
[TBL] [Abstract][Full Text] [Related]
3. Reactivation of brain acetylcholinesterase by monoisonitrosoacetone increases the therapeutic efficacy against nerve agents in guinea pigs.
Skovira JW; O'Donnell JC; Koplovitz I; Kan RK; McDonough JH; Shih TM
Chem Biol Interact; 2010 Sep; 187(1-3):318-24. PubMed ID: 20230808
[TBL] [Abstract][Full Text] [Related]
4. In vivo reactivation by oximes of inhibited blood, brain and peripheral tissue cholinesterase activity following exposure to nerve agents in guinea pigs.
Shih TM; Skovira JW; O'Donnell JC; McDonough JH
Chem Biol Interact; 2010 Sep; 187(1-3):207-14. PubMed ID: 20223229
[TBL] [Abstract][Full Text] [Related]
5. An in vitro comparative study on the reactivation of nerve agent-inhibited guinea pig and human acetylcholinesterases by oximes.
Luo C; Tong M; Chilukuri N; Brecht K; Maxwell DM; Saxena A
Biochemistry; 2007 Oct; 46(42):11771-9. PubMed ID: 17900152
[TBL] [Abstract][Full Text] [Related]
6. Oral administration of pyridostigmine bromide and huperzine A protects human whole blood cholinesterases from ex vivo exposure to soman.
Gordon RK; Haigh JR; Garcia GE; Feaster SR; Riel MA; Lenz DE; Aisen PS; Doctor BP
Chem Biol Interact; 2005 Dec; 157-158():239-46. PubMed ID: 16256090
[TBL] [Abstract][Full Text] [Related]
7. Differential profiles of cholinesterase inhibition and neurobehavioral effects in rats exposed to fenamiphos or profenofos.
McDaniel KL; Moser VC
Neurotoxicol Teratol; 2004; 26(3):407-15. PubMed ID: 15113602
[TBL] [Abstract][Full Text] [Related]
8. Effects of 4-pyridine aldoxime on nerve agent-inhibited acetylcholinesterase activity in guinea pigs.
Shih TM; Skovira JW; McDonough JH
Arch Toxicol; 2009 Dec; 83(12):1083-9. PubMed ID: 19763542
[TBL] [Abstract][Full Text] [Related]
9. Retrospective detection of exposure to nerve agents: analysis of phosphofluoridates originating from fluoride-induced reactivation of phosphylated BuChE.
van der Schans MJ; Polhuijs M; van Dijk C; Degenhardt CE; Pleijsier K; Langenberg JP; Benschop HP
Arch Toxicol; 2004 Sep; 78(9):508-24. PubMed ID: 15170525
[TBL] [Abstract][Full Text] [Related]
10. Differential sensitivity of blood, peripheral, and central cholinesterases in beagle dogs following dietary exposure to chlorpyrifos.
Marable BR; Maurissen JP; Mattsson JL; Billington R
Regul Toxicol Pharmacol; 2007 Apr; 47(3):240-8. PubMed ID: 17141929
[TBL] [Abstract][Full Text] [Related]
11. Asymmetric fluorogenic organophosphates for the development of active organophosphate hydrolases with reversed stereoselectivity.
Amitai G; Adani R; Yacov G; Yishay S; Teitlboim S; Tveria L; Limanovich O; Kushnir M; Meshulam H
Toxicology; 2007 Apr; 233(1-3):187-98. PubMed ID: 17129656
[TBL] [Abstract][Full Text] [Related]
12. Cholinesterase inhibitors modify the activity of intrinsic cardiac neurons.
Darvesh S; Arora RC; Martin E; Magee D; Hopkins DA; Armour JA
Exp Neurol; 2004 Aug; 188(2):461-70. PubMed ID: 15246845
[TBL] [Abstract][Full Text] [Related]
13. Analysis of inhibition, reactivation and aging kinetics of highly toxic organophosphorus compounds with human and pig acetylcholinesterase.
Aurbek N; Thiermann H; Szinicz L; Eyer P; Worek F
Toxicology; 2006 Jul; 224(1-2):91-9. PubMed ID: 16720069
[TBL] [Abstract][Full Text] [Related]
14. An attempt to assess functionally minimal acetylcholinesterase activity necessary for survival of rats intoxicated with nerve agents.
Bajgar J; Fusek J; Kassa J; Jun D; Kuca K; Hajek P
Chem Biol Interact; 2008 Sep; 175(1-3):281-5. PubMed ID: 18579126
[TBL] [Abstract][Full Text] [Related]
15. The influence of inhibitors and other factors on cholinesterases.
Bajgar J
Sb Ved Pr Lek Fak Karlovy Univerzity Hradci Kralove; 1991; 34(1):5-77. PubMed ID: 1759111
[TBL] [Abstract][Full Text] [Related]
16. Aging-resistant organophosphate bioscavenger based on polyethylene glycol-conjugated F338A human acetylcholinesterase.
Mazor O; Cohen O; Kronman C; Raveh L; Stein D; Ordentlich A; Shafferman A
Mol Pharmacol; 2008 Sep; 74(3):755-63. PubMed ID: 18523134
[TBL] [Abstract][Full Text] [Related]
17. Effects of sarin on the operant behavior of guinea pigs.
Langston JL; Adkins AL; Moran AV; Rockwood GA; Deford MS
Neurotoxicol Teratol; 2005; 27(6):841-53. PubMed ID: 16046097
[TBL] [Abstract][Full Text] [Related]
18. Advantages of the WRAIR whole blood cholinesterase assay: comparative analysis to the micro-Ellman, Test-mate ChE, and Michel (DeltapH) assays.
Haigh JR; Lefkowitz LJ; Capacio BR; Doctor BP; Gordon RK
Chem Biol Interact; 2008 Sep; 175(1-3):417-20. PubMed ID: 18555983
[TBL] [Abstract][Full Text] [Related]
19. An evaluation of reactivating and therapeutic efficacy of newly developed oximes (K206, K269) and commonly used oximes (obidoxime, HI-6) in cyclosarin-poisoned rats and mice.
Kassa J; Karasova J; Musilek K; Kuca K; Bajgar J
Clin Toxicol (Phila); 2009 Jan; 47(1):72-6. PubMed ID: 18686075
[TBL] [Abstract][Full Text] [Related]
20. Evaluation of HI 6 treatment after percutaneous VR exposure by use of a kinetic-based dynamic computer model.
Aurbek N; Thiermann H; Szinicz L; Worek F
Toxicology; 2007 Apr; 233(1-3):173-9. PubMed ID: 16904808
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
